7Indexed trials
drug · Product Intelligence
Midazolam
Pipeline Intelligence
Midazolam: 7 indexed trials, 7 sponsors; 1 linked Orange Book patents and 13 FDA-linked events where matched.
7Sponsors
1Orange Book patent links
13FDA-linked events
Development evidence
NCT02579928Yale University · depressionPHASE4
NCT02593643Sunnybrook Health Sciences Centre · depressionEARLY_PHASE1
NCT03239743Valley Anesthesiology Consultants · anxietyNA
NCT04475848Hoffmann-La Roche · autismPHASE1
NCT04675372China International Neuroscience Institution · other_neurologyPHASE4
NCT06139692Jinling Hospital, China · strokePHASE4
NCT07626255Pakistan Air Force (PAF) Hospital Islamabad · epilepsyPHASE4
FDA / patent evidence
10966990MIDAZOLAM IN 0.9% SODIUM CHLORIDE · app 2118442038-06-20
Regulatory context
FDA_APPROVALMIDAZOLAM IN 0.8% SODIUM CHLORIDE · 2025-05-01
FDA_APPROVALMIDAZOLAM IN 0.9% SODIUM CHLORIDE · 2023-04-17
FDA_APPROVALMIDAZOLAM IN 0.9% SODIUM CHLORIDE · 2021-03-22
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2017-03-28
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2008-11-10
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2005-05-02
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2003-09-04
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2000-11-01
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2000-06-26
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2000-06-23
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2000-06-23
FDA_APPROVALMIDAZOLAM HYDROCHLORIDE · 2000-06-20
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.